Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial

• Main Authors: Yayun Cui (Author), Yifu He (Author), Changlu Hu (Author), Congyin Tu (Author), Jin Huang (Author), Xiaofeng Zhu (Author), Chunbao Zang (Author), Kaiyang Ding (Author), Bihong Zhan (Author), Yufei Zhao (Author), Liting Qian (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To explore the effect and safety of avatrombopag for chemotherapy-induced thrombocytopenia (CIT).Methods: This multicenter, open-label, single-arm trial enrolled CIT patients in eight centers from October 2020 to April 2021. The participants received avatrombopag tablets 60 mg once a day...